Vitrolife AB financials
Vitrolife AB
Country: SE Reporting currency: SEK Latest annual report: 2024-12-31
LEI:
5493001WDZMONMSPPR49 Financial statements
(SEK, as reported — unscaled; 95 line items across 2 annual periods)
| Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | SEK 3.61B | SEK 3.51B |
| Cost of sales | SEK 1.47B | SEK 1.53B |
| Gross profit | SEK 2.14B | SEK 1.98B |
| Other income | SEK 11.0M | SEK 5.0M |
| Administrative expenses | SEK 478.0M | SEK 433.0M |
| Operating profit (EBIT) | SEK 783.0M | -SEK 3.59B |
| Finance costs | SEK 134.0M | SEK 142.0M |
| Profit before tax | SEK 674.0M | -SEK 3.71B |
| Income tax expense | SEK 160.0M | SEK 139.0M |
| Profit for the year | SEK 514.0M | -SEK 3.85B |
| — attributable to owners | SEK 513.0M | -SEK 3.85B |
| — attributable to NCI | SEK 1.0M | SEK 0 |
| Total comprehensive income | SEK 1.05B | -SEK 3.87B |
| Per share | ||
| Basic EPS | SEK 3.79 | SEK -28.44 |
| Diluted EPS | SEK 3.78 | SEK -28.44 |
| Free cash flow / share | SEK 5.99 | SEK 5.10 |
| Cash flow statement | ||
| Net cash from operating activities | SEK 907.0M | SEK 757.0M |
| Net cash from investing activities | -SEK 377.0M | -SEK 124.0M |
| Purchase of PP&E (capex) | SEK 92.0M | SEK 67.0M |
| Purchase of intangibles | SEK 110.0M | SEK 52.0M |
| Net cash from financing activities | -SEK 286.0M | -SEK 300.0M |
| Dividends paid | SEK 135.0M | SEK 115.0M |
| Proceeds from borrowings | SEK 13.0M | SEK 0 |
| Lease liability payments | SEK 46.0M | SEK 31.0M |
| Net change in cash | SEK 245.0M | SEK 333.0M |
| Balance sheet | ||
| Total assets | SEK 17.45B | SEK 16.33B |
| Non-current assets | SEK 15.09B | SEK 14.41B |
| Property, plant & equipment | SEK 428.0M | SEK 349.0M |
| Intangible assets & goodwill | SEK 10.12B | SEK 9.59B |
| Current assets | SEK 2.36B | SEK 1.91B |
| Cash & equivalents | SEK 1.14B | SEK 861.0M |
| Total equity | SEK 13.64B | SEK 12.72B |
| — attributable to owners | SEK 13.64B | SEK 12.72B |
| Non-controlling interests | SEK 2.0M | SEK 1.0M |
| Non-current liabilities | SEK 3.10B | SEK 3.05B |
| Long-term borrowings | SEK 1.84B | SEK 1.88B |
| Lease liabilities (non-current) | SEK 92.0M | SEK 67.0M |
| Current liabilities | SEK 705.0M | SEK 557.0M |
| Current portion of long-term borrowings | SEK 115.0M | SEK 114.0M |
| Lease liabilities (current) | SEK 45.0M | SEK 33.0M |
| Deferred tax liabilities | SEK 1.06B | SEK 1.03B |
| Derived metrics | ||
| Free cash flow | SEK 815.0M | SEK 690.0M |
| Operating margin | 21.7% | -102.2% |
| Net margin | 14.2% | -109.7% |
| Return on equity | 3.8% | -30.3% |
| Cash conversion ratio | 1.76× | -0.20× |
| Capex coverage | 9.86× | 11.30× |
| Other reported items | ||
| Accruals Classified As Current | SEK 216.0M | SEK 165.0M |
| Adjustments For Decrease Increase In Inventories | SEK 2.0M | -SEK 15.0M |
| Adjustments For Decrease Increase In Trade and Other Receivables | -SEK 174.0M | -SEK 95.0M |
| Adjustments For Increase Decrease In Trade and Other Payables | SEK 104.0M | -SEK 9.0M |
| Cash Flows From Losing Control of Subsidiaries Or Other Businesses Classified As Investing Activities | -SEK 22.0M | SEK 0 |
| Cash Flows From Used In Increase Decrease In Current Borrowings | -SEK 3.0M | -SEK 27.0M |
| Cash Flows From Used In Operations Before Changes In Working Capital | SEK 975.0M | SEK 876.0M |
| Comprehensive Income Attributable To Noncontrolling Interests | SEK 1.0M | -SEK 1.0M |
| Comprehensive Income Attributable To Owners of Parent | SEK 1.04B | -SEK 3.87B |
| Current Prepayments and Other Current Assets | SEK 66.0M | SEK 57.0M |
| Current Tax Assets Current | SEK 33.0M | SEK 45.0M |
| Current Tax Liabilities Current | SEK 26.0M | SEK 19.0M |
| Deferred Tax Assets | SEK 144.0M | SEK 111.0M |
| Depreciation Expense | SEK 442.0M | SEK 4.72B |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners | SEK 149.0M | — |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | SEK 1.10 | — |
| Dividends Recognised As Distributions To Owners of Parent | SEK 135.0M | SEK 115.0M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | SEK 29.0M | -SEK 50.0M |
| Equity and Liabilities | SEK 17.45B | SEK 16.33B |
| Finance Income | SEK 25.0M | SEK 19.0M |
| Gains Losses On Exchange Differences On Translation Net of Tax | SEK 532.0M | -SEK 20.0M |
| Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | — | SEK 4.30B |
| Income Taxes Paid Refund Classified As Operating Activities | -SEK 208.0M | -SEK 213.0M |
| Increase Decrease Through Acquisition of Subsidiary | -SEK 7.0M | -SEK 10.0M |
| Increase Decrease Through Sharebased Payment Transactions | SEK 14.0M | SEK 17.0M |
| Increase Decrease Through Transfers and Other Changes Equity | — | -SEK 35.0M |
| Inventories Total | SEK 422.0M | SEK 413.0M |
| Issued Capital | SEK 28.0M | SEK 28.0M |
| Liabilities | SEK 3.81B | SEK 3.61B |
| Other Comprehensive Income | SEK 532.0M | -SEK 20.0M |
| Other Current Liabilities | SEK 100.0M | SEK 56.0M |
| Other Expense By Function | SEK 18.0M | SEK 4.33B |
| Other Inflows Outflows of Cash Classified As Investing Activities | -SEK 112.0M | SEK 0 |
| Other Intangible Assets | SEK 4.34B | SEK 4.31B |
| Other Noncurrent Financial Assets | SEK 54.0M | SEK 50.0M |
| Other Noncurrent Liabilities | SEK 65.0M | SEK 0 |
| Other Receivables | SEK 53.0M | SEK 34.0M |
| Other Reserves | SEK 1.68B | SEK 1.14B |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | SEK 4.0M | SEK 6.0M |
| Purchase of Interests In Associates | SEK 0 | SEK 10.0M |
| Purchase of Other Longterm Assets Classified As Investing Activities | SEK 45.0M | SEK 0 |
| Repayments of Current Borrowings | SEK 114.0M | SEK 126.0M |
| Research and Development Expense | SEK 117.0M | SEK 127.0M |
| Retained Earnings | -SEK 1.61B | -SEK 1.99B |
| Sales and Marketing Expense | SEK 754.0M | SEK 684.0M |
| Share Premium | SEK 13.54B | SEK 13.54B |
| Trade and Other Payables To Trade Suppliers | SEK 203.0M | SEK 171.0M |
| Trade Receivables | SEK 648.0M | SEK 503.0M |
Methodology
Every line item above is a fact tagged in Vitrolife AB's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (SEK), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.